stuart dry eye drug ig thumbnail
June 26, 2025

Stuart Therapeutics Unveils Phase III Results for Novel Dry Eye Candidate

ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…

Alcon TRYPTYR FDA approval
May 29, 2025

Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease 

TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland)  has…

Discover our fascinating content at issuu

explore